These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27550872)

  • 1. Synthetic Cannabinoid Exposure: A New Risk for Children?
    Adair A; Greene SC; Greeley CS; Coleman RD; Shekerdemian LS
    Clin Pediatr (Phila); 2016 Oct; 55(11):1075-7. PubMed ID: 27550872
    [No Abstract]   [Full Text] [Related]  

  • 2. Organic and synthetic cannabinoid use in adolescents.
    Bhatty S; Wu W
    Pediatr Ann; 2013 Jan; 42(1):31-5. PubMed ID: 23316832
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational cannabinoid use: The hazards behind the "high".
    Wright S; Metts J
    J Fam Pract; 2016 Nov; 65(11):770-779. PubMed ID: 28087865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spice and all things nasty: the challenge of synthetic cannabinoids.
    Kalk NJ; Boyd A; Strang J; Finch E
    BMJ; 2016 Oct; 355():i5639. PubMed ID: 27777237
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic cannabinoid and marijuana exposures reported to poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Hyperemesis Syndrome Among Pregnant Women: Beyond Diagnosis--Potentially Harmful Consequences.
    LaForgue EJ; Lesage A; Schreck B; Guerlais M; Victorri-Vigneau C
    J Stud Alcohol Drugs; 2020 Nov; 81(6):824-825. PubMed ID: 33308413
    [No Abstract]   [Full Text] [Related]  

  • 8. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid hyperemesis.
    Sannarangappa V; Tan C
    Intern Med J; 2009 Nov; 39(11):777-8. PubMed ID: 19912406
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Marijuana and Synthetic Cannabinoid-Induced Toxic Myocarditis and End-Stage Cardiomyopathy: Management With Mechanical Circulatory Support as a Bridge-to-Transplantation.
    Hill GED; Izquierdo DA; Boettcher BT; Pagel PS
    J Cardiothorac Vasc Anesth; 2019 Sep; 33(9):2508-2512. PubMed ID: 30606509
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case of brodifacoum-contaminated synthetic cannabinoid.
    Riley SB; Sochat M; Moser K; Lynch KL; Tochtrop R; Isbell TS; Scalzo A
    Clin Toxicol (Phila); 2019 Feb; 57(2):143-144. PubMed ID: 30148410
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical presentation of intoxication due to synthetic cannabinoids.
    Cohen J; Morrison S; Greenberg J; Saidinejad M
    Pediatrics; 2012 Apr; 129(4):e1064-7. PubMed ID: 22430444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoid-induced psychosis: two adolescent cases.
    Oluwabusi OO; Lobach L; Akhtar U; Youngman B; Ambrosini PJ
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):393-5. PubMed ID: 23083027
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
    Argamany JR; Reveles KR; Duhon B
    Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid Hyperemesis Syndrome: Descriptive Overview of an Under-Recognized Diagnosis.
    Braver O; Leibman Y
    Isr Med Assoc J; 2015 May; 17(5):324-5. PubMed ID: 26137664
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study.
    Wilson W; Mathew R; Turkington T; Hawk T; Coleman RE; Provenzale J
    J Addict Dis; 2000; 19(1):1-22. PubMed ID: 10772599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015.
    Nolan ML; Allen B; Kunins HV; Paone D
    Int J Drug Policy; 2016 Aug; 34():101-3. PubMed ID: 27453146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.